We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 17th:
Tailored Brands, Inc. : This specialty apparel retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.4% over the last 60 days.
BeldenInc. (BDC - Free Report) : This retailer of footwear has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.9% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Value Stocks to Buy for October 17th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 17th:
Tailored Brands, Inc. : This specialty apparel retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.4% over the last 60 days.
Tailored Brands, Inc. Price and Consensus
Tailored Brands, Inc. price-consensus-chart | Tailored Brands, Inc. Quote
Tailored Brands has a price-to-earnings ratio (P/E) of 9.11 compared with 26.30 for the industry. The company possesses a Value Score of A.
Tailored Brands, Inc. PE Ratio (TTM)
Tailored Brands, Inc. pe-ratio-ttm | Tailored Brands, Inc. Quote
BeldenInc. (BDC - Free Report) : This retailer of footwear has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
Belden Inc Price and Consensus
Belden Inc price-consensus-chart | Belden Inc Quote
Belden has a price-to-earnings ratio (P/E) of 9.72, compared with 12.30 for the industry. The company possesses a Value Score of A.
Belden Inc PE Ratio (TTM)
Belden Inc pe-ratio-ttm | Belden Inc Quote
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.9% over the last 60 days.
Werner Enterprises, Inc. Price and Consensus
Werner Enterprises, Inc. price-consensus-chart | Werner Enterprises, Inc. Quote
Werner has a price-to-earnings ratio (P/E) of 14.57, compared with 15.80 for the industry. The company possesses a Value Score of A.
Werner Enterprises, Inc. PE Ratio (TTM)
Werner Enterprises, Inc. pe-ratio-ttm | Werner Enterprises, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>